Cargando…

Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages

Immunosuppression is a significant factor in the progression of tumor invasion and metastasis. Melatonin, a well-known hormone, has certain cytotoxic and immune regulatory effects to inhibit tumor function. Exosomes are small membrane vesicles released by many kinds of cells, which contain different...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Liang, Liu, Jiatao, Liu, Qingqing, Liu, Yu, Fan, Lulu, Wang, Fang, Yu, Hanqing, Li, Yuhuan, Bu, Lijia, Li, Xiaoqiu, Wei, Wei, Wang, Hua, Sun, Guoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485628/
https://www.ncbi.nlm.nih.gov/pubmed/28655998
http://dx.doi.org/10.7150/ijbs.19642
_version_ 1783246107372945408
author Cheng, Liang
Liu, Jiatao
Liu, Qingqing
Liu, Yu
Fan, Lulu
Wang, Fang
Yu, Hanqing
Li, Yuhuan
Bu, Lijia
Li, Xiaoqiu
Wei, Wei
Wang, Hua
Sun, Guoping
author_facet Cheng, Liang
Liu, Jiatao
Liu, Qingqing
Liu, Yu
Fan, Lulu
Wang, Fang
Yu, Hanqing
Li, Yuhuan
Bu, Lijia
Li, Xiaoqiu
Wei, Wei
Wang, Hua
Sun, Guoping
author_sort Cheng, Liang
collection PubMed
description Immunosuppression is a significant factor in the progression of tumor invasion and metastasis. Melatonin, a well-known hormone, has certain cytotoxic and immune regulatory effects to inhibit tumor function. Exosomes are small membrane vesicles released by many kinds of cells, which contain different macromolecules, such as mRNAs and microRNAs (miRNAs), and proteins that can mediate communications between cells. Tumor-derived exosomes may cause immunosuppression, however, it is unknown whether melatonin can attenuate an immunosuppressive status by altering the function of tumor-derived exosomes. In the present study, we evaluated the effects of hepatocellularcarcinoma-derived exosomes (Exo-con) and exosomes derived from hepatocellularcarcinoma cells treated with 0.1 mM melatonin (Exo-MT), on the expression of inflammatory factors and programmed death ligand 1(PD-L1) by co-culturing Exo-con and Exo-MT, respectively, with macrophages differentiated from THP-1 cells or RAW264.7 cells. Our in vitro results indicate that Exo-MT can downregulate the expression of PD-L1 on macrophages while Exo-con can upregulate the expression of PD-L1 through flow cytometry and immunofluorescence analysis. In addition, Exo-con upregulates the secretion of cytokines, such as IL-6, IL-10, IL-1β, and TNF-α in macrophages. Accordingly, Exo-MT could attenuate the high expression of these inflammatory cytokines. Furthermore, in vivo experiments confirmed the results found in vitro. PD-L1 expression and cytokine secretion were lower in the Exo-MT group compared with those in the Exo-con group. Working to identify a specific mechanism, our research shows that Exo-MT decreases STAT3 activation compared to the Exo-con group. In summary, we found exosomes from melatonin treated hepatocellularcarcinoma cells alters the immunosupression status through STAT3 pathway in macrophages. Our study may provide a new avenue to investigate the mechanisms of melatonin in regulating an immunosuppressive status.
format Online
Article
Text
id pubmed-5485628
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-54856282017-06-27 Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages Cheng, Liang Liu, Jiatao Liu, Qingqing Liu, Yu Fan, Lulu Wang, Fang Yu, Hanqing Li, Yuhuan Bu, Lijia Li, Xiaoqiu Wei, Wei Wang, Hua Sun, Guoping Int J Biol Sci Research Paper Immunosuppression is a significant factor in the progression of tumor invasion and metastasis. Melatonin, a well-known hormone, has certain cytotoxic and immune regulatory effects to inhibit tumor function. Exosomes are small membrane vesicles released by many kinds of cells, which contain different macromolecules, such as mRNAs and microRNAs (miRNAs), and proteins that can mediate communications between cells. Tumor-derived exosomes may cause immunosuppression, however, it is unknown whether melatonin can attenuate an immunosuppressive status by altering the function of tumor-derived exosomes. In the present study, we evaluated the effects of hepatocellularcarcinoma-derived exosomes (Exo-con) and exosomes derived from hepatocellularcarcinoma cells treated with 0.1 mM melatonin (Exo-MT), on the expression of inflammatory factors and programmed death ligand 1(PD-L1) by co-culturing Exo-con and Exo-MT, respectively, with macrophages differentiated from THP-1 cells or RAW264.7 cells. Our in vitro results indicate that Exo-MT can downregulate the expression of PD-L1 on macrophages while Exo-con can upregulate the expression of PD-L1 through flow cytometry and immunofluorescence analysis. In addition, Exo-con upregulates the secretion of cytokines, such as IL-6, IL-10, IL-1β, and TNF-α in macrophages. Accordingly, Exo-MT could attenuate the high expression of these inflammatory cytokines. Furthermore, in vivo experiments confirmed the results found in vitro. PD-L1 expression and cytokine secretion were lower in the Exo-MT group compared with those in the Exo-con group. Working to identify a specific mechanism, our research shows that Exo-MT decreases STAT3 activation compared to the Exo-con group. In summary, we found exosomes from melatonin treated hepatocellularcarcinoma cells alters the immunosupression status through STAT3 pathway in macrophages. Our study may provide a new avenue to investigate the mechanisms of melatonin in regulating an immunosuppressive status. Ivyspring International Publisher 2017-05-16 /pmc/articles/PMC5485628/ /pubmed/28655998 http://dx.doi.org/10.7150/ijbs.19642 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Cheng, Liang
Liu, Jiatao
Liu, Qingqing
Liu, Yu
Fan, Lulu
Wang, Fang
Yu, Hanqing
Li, Yuhuan
Bu, Lijia
Li, Xiaoqiu
Wei, Wei
Wang, Hua
Sun, Guoping
Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages
title Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages
title_full Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages
title_fullStr Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages
title_full_unstemmed Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages
title_short Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages
title_sort exosomes from melatonin treated hepatocellularcarcinoma cells alter the immunosupression status through stat3 pathway in macrophages
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485628/
https://www.ncbi.nlm.nih.gov/pubmed/28655998
http://dx.doi.org/10.7150/ijbs.19642
work_keys_str_mv AT chengliang exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages
AT liujiatao exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages
AT liuqingqing exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages
AT liuyu exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages
AT fanlulu exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages
AT wangfang exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages
AT yuhanqing exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages
AT liyuhuan exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages
AT bulijia exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages
AT lixiaoqiu exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages
AT weiwei exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages
AT wanghua exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages
AT sunguoping exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages